Ardelyx

Developer of therapeutics for the gastrointestinal tract, cardio-renal, GI, and metabolic diseases

placeFremont, California, United States calendar_todayFounded 2007 groups37 employees language ardelyx.com

Registered entities

Innovation

35 patent families (25 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 7,155 times.

YearFilings
201511
201612
201712
201814
201914
202013
202111
202214
202315
202413
202512
20265

Social engagement

Social engagement: 27.4K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

13 investors on record; lead investors include New Enterprise Associates, CMEA Capital, Amgen Business Development; 2 have since exited.

Investor typeCountShare
Venture capital754%
Private equity323%
Other / undisclosed323%

Hiring activity

Hires frequently

70 roles tracked across 9 of the last 12 months

10 Jun 2026 · Area Business Director (Gastroenterology) - Southern Indiana · Evansville

10 Jun 2026 · Zone Access Manager Nephrology · Los Angeles

10 Jun 2026 · Field Reimbursement Manager - Richmond, VA · Virginia Beach

10 Jun 2026 · Zone Access Manager - Nephrology · San Jose

10 Jun 2026 · Clinical Trial Manager · Newark

Based on job postings tracked across public sources.

Coming soon